A detailed history of Citigroup Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Citigroup Inc holds 193,658 shares of HAE stock, worth $13.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
193,658
Previous 230,375 15.94%
Holding current value
$13.7 Million
Previous $19.1 Million 18.33%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$72.45 - $91.58 $2.66 Million - $3.36 Million
-36,717 Reduced 15.94%
193,658 $15.6 Million
Q2 2024

Aug 12, 2024

BUY
$81.24 - $97.37 $12.4 Million - $14.9 Million
152,935 Added 197.49%
230,375 $19.1 Million
Q1 2024

May 10, 2024

SELL
$71.24 - $85.35 $5.18 Million - $6.21 Million
-72,759 Reduced 48.44%
77,440 $6.61 Million
Q4 2023

Feb 09, 2024

SELL
$80.59 - $92.61 $82,927 - $95,295
-1,029 Reduced 0.68%
150,199 $12.8 Million
Q3 2023

Nov 09, 2023

SELL
$82.56 - $93.49 $2.26 Million - $2.56 Million
-27,390 Reduced 15.33%
151,228 $13.5 Million
Q2 2023

Aug 10, 2023

BUY
$80.84 - $89.45 $6 Million - $6.64 Million
74,190 Added 71.04%
178,618 $15.2 Million
Q1 2023

May 11, 2023

SELL
$72.75 - $90.6 $3 Million - $3.74 Million
-41,268 Reduced 28.32%
104,428 $8.64 Million
Q4 2022

Feb 09, 2023

BUY
$73.85 - $86.14 $3.55 Million - $4.14 Million
48,101 Added 49.29%
145,696 $11.5 Million
Q3 2022

Nov 10, 2022

SELL
$63.3 - $78.66 $2.29 Million - $2.84 Million
-36,131 Reduced 27.02%
97,595 $7.23 Million
Q2 2022

Aug 10, 2022

BUY
$49.27 - $66.08 $720,524 - $966,353
14,624 Added 12.28%
133,726 $8.72 Million
Q1 2022

May 12, 2022

BUY
$43.77 - $63.22 $318,251 - $459,672
7,271 Added 6.5%
119,102 $7.53 Million
Q4 2021

Feb 10, 2022

SELL
$49.55 - $74.59 $101,032 - $152,089
-2,039 Reduced 1.79%
111,831 $5.93 Million
Q3 2021

Nov 10, 2021

BUY
$57.6 - $70.59 $6.56 Million - $8.04 Million
113,870 New
113,870 $8.04 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.63B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.